Talks
WISDOM Trial: Risk Model Validity
April 9, 2026
Share
WISDOM Trial: Mammogram Rates
April 9, 2026
Share
WISDOM Trial: Biopsy Rates
April 9, 2026
Share
WISDOM Trial: Non-Inferiority Results
April 9, 2026
Share
WISDOM Trial: Risk-Based Screening Strategy
April 9, 2026
Share
WISDOM Trial: Study Design & Participants
April 9, 2026
Share
WISDOM Trial: Primary Objective
April 9, 2026
Share
Rethinking Breast Cancer Screening
April 9, 2026
Share
HypoG-01 Trial: Key Takeaways
March 13, 2026
Share
HypoG-01 Trial: Safety Profile
March 13, 2026
Share
HypoG-01 Trial: Oncologic Outcomes
March 13, 2026
Share
HypoG-01 Trial: Primary Outcome Results
March 13, 2026
Share
HypoG-01 Trial: Primary Endpoint Definition
March 13, 2026
Share
HypoG-01 Trial: Treatment Arms
March 13, 2026
Share
HypoG-01 Trial: Study Design
March 13, 2026
Share
HypoG-01 Trial: Study Objective
March 13, 2026
Share
HypoG-01 Trial: Clinical Background
March 13, 2026
Share
HypoG-01 Trial: Overview
March 13, 2026
Share
OPBC-07/microNAC: Clinical Implications
February 24, 2026
Share
OPBC-07/microNAC: Residual Nodal Disease
February 24, 2026
Share
OPBC-07/microNAC: Key Findings
February 24, 2026
Share
OPBC-07/microNAC: Comparative Outcomes
February 24, 2026
Share
OPBC-07/microNAC: Study Profile
February 24, 2026
Share
OPBC-07/microNAC: Methods
February 24, 2026
Share
OPBC-07/microNAC: Primary Objective
February 24, 2026
Share
OPBC-07/microNAC: Modern Clinical Practice
February 24, 2026
Share
OPBC-07/microNAC: Standard Treatment and the Shift Toward Surgical De-Escalation
February 24, 2026
Share
OPBC-07/microNAC: Study Overview
February 24, 2026
Share
Supremo Trial
January 15, 2026
Share
Close button
Why are you reporting this TALK?